Additional Proxy Soliciting Materials (definitive) (defa14a)
05 5월 2023 - 8:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the Registrant ☑
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
|
|
|
Preliminary Proxy Statement
|
☐
|
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐
|
|
|
Definitive Proxy Statement
|
☑
|
|
|
Definitive Additional Materials
|
☐
|
|
|
Soliciting Material under §240.14a-12
|
Eterna Therapeutics Inc.
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
Payment of Filing Fee (Check all boxes that apply):
☑
|
|
|
No fee required
|
☐
|
|
|
Fee paid previously with preliminary materials
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11
|
NTN Buzztime (AMEX:NTN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
NTN Buzztime (AMEX:NTN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
NTN Buzztime Inc New (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More Eterna Therapeutics Inc. News Articles